Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Messmore

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Pediatric Hematology/Oncology|January 1, 1983
Sinus histiocytosis with massive lymphadenopathy: remission with chemotherapyC R Suarez, W P Zeller, S Silberman, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Clinical differentiation of low molecular weight heparinsE F Mammen, J Arcelus, H Messmore, et al.
Leukemia|March 1, 1992
Phase II trial of recombinant human interferon alpha in myelodysplastic syndromesS Nand, T Ellis, H Messmore, et al.
Journal of the American Academy of Dermatology|February 1, 1992
Scleredema and smoldering myelomaK T Schmidt, P Gattuso, H Messmore, et al.
American Journal of Hematology|May 1, 1990
Leukemic transformation in polycythemia vera: analysis of risk factorsS Nand, H Messmore, S G Fisher, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplastyJ Fareed, J M Walenga, F Leya, et al.
Thrombosis Research|March 15, 1982
Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparinE Sache, M Maillard, H Bertrand, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Differential effects of unfractionated heparin and low-molecular-weight heparins on tissue thromboplastin inhibition testR Gerbutavicius, O Iqbal, H Messmore, et al.
Haematology and Blood Transfusion|January 1, 1985
A model scheme of hematopoietic cell differentiation based on multiple marker analysis of leukemia-lymphomas: T cell lineageJ Minowada, H G Drexler, M Menon, et al.
The Canadian Journal of Cardiology|June 1, 1995
Successful treatment of heparin-associated thrombocytopenia and thrombosis using HirulogJ R Chamberlin, B Lewis, F Leya, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Pediatric Hematology/Oncology|January 1, 1983
Sinus histiocytosis with massive lymphadenopathy: remission with chemotherapyC R Suarez, W P Zeller, S Silberman, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Clinical differentiation of low molecular weight heparinsE F Mammen, J Arcelus, H Messmore, et al.
Leukemia|March 1, 1992
Phase II trial of recombinant human interferon alpha in myelodysplastic syndromesS Nand, T Ellis, H Messmore, et al.
Journal of the American Academy of Dermatology|February 1, 1992
Scleredema and smoldering myelomaK T Schmidt, P Gattuso, H Messmore, et al.
American Journal of Hematology|May 1, 1990
Leukemic transformation in polycythemia vera: analysis of risk factorsS Nand, H Messmore, S G Fisher, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplastyJ Fareed, J M Walenga, F Leya, et al.
Thrombosis Research|March 15, 1982
Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparinE Sache, M Maillard, H Bertrand, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Differential effects of unfractionated heparin and low-molecular-weight heparins on tissue thromboplastin inhibition testR Gerbutavicius, O Iqbal, H Messmore, et al.
Haematology and Blood Transfusion|January 1, 1985
A model scheme of hematopoietic cell differentiation based on multiple marker analysis of leukemia-lymphomas: T cell lineageJ Minowada, H G Drexler, M Menon, et al.
The Canadian Journal of Cardiology|June 1, 1995
Successful treatment of heparin-associated thrombocytopenia and thrombosis using HirulogJ R Chamberlin, B Lewis, F Leya, et al.
Pageof 2